STH SABR Referral Form - Oligometastatic Disease, Primary HCC and Retreatment
This referral form is currently under development. DO NOT USE for live referrals yet.
Referral for Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastatic Disease, primary HCC and retreatment
Weston Park Cancer Centre (WPCC) is currently commissioned for the treatment of oligometastatic disease (1-3 mets) and primary hepatocellular carcinoma.
Main eligibility criteria
- Oligometastatic cancer (3 or fewer sites of metastatic disease): Spine (maximum 2 mets), liver, adrenal, lymph nodes, lung and/or bone.
- Retreat: cancer that has recurred in a site treated previously with radiotherapy (pelvic and spine only). These patients will need to be referred to Leeds.
- Primary hepatocellular carcinoma
- Disease free interval >6 months since treatment of primary malignancy (unless colorectal liver met which can be treated if synchronous to primary diagnosis).
To Refer
Potential patients for SABR should be referred to the SABR MDT at WPH which takes place at 8.30 on a Friday morning (MS Teams).
Patients with metastasis deemed not eligible for treatment in Sheffield may be referred onto other centres where site specific SABR treatment is currently available, if the WPH SABR MDT deems SABR appropriate (e.g. re-treats).
Please use the inclusion criteria below as a general guide when completing the SABR referral form. Referrals will still be discussed if key inclusion criteria are not met.
The SABR MDT is every Friday at 8.30am (MS Teams). For discussion in the same week, the referral needs to be received by Wednesday at 12 noon.
If there are issues with this electronic form, paper-based referrals can still be made using the referral form emailed to sth.sabrmdt@nhs.net.